Evidence map›Paper›PMID 42401978›Full record

ArticleActa neuropathologica communications2026

Regional wasteosome accumulation across neurodegenerative diseases points to a shared underlying mechanism potentially related to glymphatic insufficiency.

Raquel Alsina, Marta Riba, Marina Sartorio, Clara Romera, Jordi Riu, Gerard Vilaplana, Iban Aldecoa, Yaroslau Compta, Raquel Sánchez-Valle, Jaume Del Valle and 3 more

Abstract read
In one paragraph

Article in Acta neuropathologica communications, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors.

Raquel Alsina *Secció de Fisiologia, Departament de Bioquímica i Fisiologia, Facultat de Farmàcia i Ciències de l'Alimentació, Universitat de Barcelona, Barcelona, 08028, Spain.
Marta Riba *Secció de Fisiologia, Departament de Bioquímica i Fisiologia, Facultat de Farmàcia i Ciències de l'Alimentació, Universitat de Barcelona, Barcelona, 08028, Spain. mriba@ub.edu.ORCID https://orcid.org/0000-0001-6293-9791
Marina SartorioSecció de Fisiologia, Departament de Bioquímica i Fisiologia, Facultat de Farmàcia i Ciències de l'Alimentació, Universitat de Barcelona, Barcelona, 08028, Spain.
Clara RomeraSecció de Fisiologia, Departament de Bioquímica i Fisiologia, Facultat de Farmàcia i Ciències de l'Alimentació, Universitat de Barcelona, Barcelona, 08028, Spain.
Jordi RiuQilimanjaro Quantum Tech, Barcelona, 08019, Spain.
Gerard VilaplanaUniversitat Politècnica de Catalunya, Barcelona, 08034, Spain.
Iban AldecoaNeurological Tissue Bank of the Biobanc-Hospital Clínic-FRCB-IDIBAPS, Barcelona, 08036, Spain.
Yaroslau ComptaInstitut de Neurociències (UBNeuro), Universitat de Barcelona, Barcelona, 08035, Spain.
Raquel Sánchez-ValleAlzheimer's Disease and Other Cognitive Disorders Unit, Neurology Service, Hospital Clínic de Barcelona, FRCB-IDIBAPS, Barcelona, 08036, Spain.
Jaume Del ValleSecció de Fisiologia, Departament de Bioquímica i Fisiologia, Facultat de Farmàcia i Ciències de l'Alimentació, Universitat de Barcelona, Barcelona, 08028, Spain.
Carme PelegríSecció de Fisiologia, Departament de Bioquímica i Fisiologia, Facultat de Farmàcia i Ciències de l'Alimentació, Universitat de Barcelona, Barcelona, 08028, Spain.
Laura Molina-Porcel *Neurological Tissue Bank of the Biobanc-Hospital Clínic-FRCB-IDIBAPS, Barcelona, 08036, Spain.
Jordi Vilaplana *Secció de Fisiologia, Departament de Bioquímica i Fisiologia, Facultat de Farmàcia i Ciències de l'Alimentació, Universitat de Barcelona, Barcelona, 08028, Spain. vilaplana@ub.edu.

Funding

Generalitat de Catalunya 2021 SGR 00288 625Ministerio de Ciencia, Innovación y Universidades FPIMinisterio de Ciencia, Innovación y Universidades FPUMinisterio de Ciencia, Innovación y Universidades Margarita SalasMinisterio de Ciencia, Innovación y Universidades PID2020-115475GB-I00
6 · The paper itself

Abstract

The glymphatic system plays a key role in clearing waste products from the brain and is essential for maintaining brain homeostasis. When dysfunctional, it appears to contribute to pathological changes that exacerbate brain disorders, including neurodegenerative diseases. Additionally, wasteosomes, also known as corpora amylacea, are structures that function as waste containers and are thought to increase in response to chronic glymphatic insufficiency. Hence, in this study, we evaluated whether the accumulation and distribution of wasteosomes are compatible with both the potential role of wasteosomes as a hallmark of the chronic glymphatic insufficiency and the presence of this insufficiency in certain neurodegenerative diseases. Accordingly, brain tissue from 185 donors was analysed, including cases of Alzheimer's disease, amyotrophic lateral sclerosis with TDP-43 proteinopathy, frontotemporal lobar degeneration with TDP-43 or tau proteinopathy, and non-diseased controls. Wasteosomes were examined across 28 brain regions comprised within 5 major brain areas, using region-specific scoring systems. Analysis was conducted through variance and covariance analyses, along with decision tree procedures. The findings reveal that wasteosomes are consistently found in specific critical regions, with a higher burden in donors with neurodegenerative diseases compared with controls. These regions are independent of the regional distribution of the underlying proteinopathy, and are potentially associated with glymphatic drainage pathways. From an integrated perspective, although further studies are required, the increased presence of wasteosomes in these critical regions across all diseased groups is consistent with the potential presence of chronic glymphatic insufficiency in these diseases.

Indexed as

BrainGlymphatic SystemNeurodegenerative DiseasesAgedAged, 80 and overAmyotrophic Lateral SclerosisFemaleHumansMaleMiddle AgedAlzheimer's diseaseAmyotrophic lateral sclerosisCorpora amylaceaFrontotemporal lobar degenerationGlymphatic systemWasteosomes

Identifiers

PMID42401978
PMCPMC13613785

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.